Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.67B 692M 599M 559M 514M 970M 65.79B 981M 6.56B 2.58B 32.92B 2.6B 2.54B 109B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.5B 667M 578M 538M 495M 935M 63.41B 945M 6.33B 2.48B 31.73B 2.5B 2.45B 105B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+0.25%
1 week+2.69%
Current month+2.82%
1 month-3.25%
3 months-15.21%
6 months-21.58%
Current year+1.13%
1 week 7.63
Extreme 7.63
8.11
1 month 7.15
Extreme 7.15
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 10/12/2017
Director of Finance/CFO 34 31/07/2019
Chief Operating Officer 45 24/08/2022
Director TitleAgeSince
Chairman 42 31/07/2019
Chairman 48 20/03/2019
Director/Board Member 46 20/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%+2.69%-16.27%+19.32% 692M
+4.86%-3.32%+52.73%+160.26% 1,043B
+1.04%-2.99%+50.87%+52.38% 621B
+0.98%-6.49%+24.00%+66.66% 435B
+0.32%+3.45%+47.06%+38.04% 361B
+0.79%-1.18%+35.63%+39.43% 293B
+0.18%-5.13%+9.17%+10.85% 251B
+4.57%+5.21%+35.91%+67.64% 220B
+2.23%-9.20%+3.78%-44.94% 201B
-2.58%-0.73%+17.16%+67.46% 164B
Average +0.86%-2.88%+26.00%+47.71% 358.98B
Weighted average by Cap. +0.99%-3.79%+38.50%+76.22%

Financials

2024 2025
Net sales 984M 146M 126M 118M 108M 204M 13.85B 207M 1.38B 542M 6.93B 547M 535M 22.96B 1.21B 179M 155M 144M 133M 250M 16.98B 253M 1.69B 665M 8.49B 671M 656M 28.13B
Net income 13.65M 2.02M 1.75M 1.63M 1.5M 2.83M 192M 2.87M 19.18M 7.53M 96.21M 7.59M 7.43M 319M 92.73M 13.74M 11.9M 11.09M 10.2M 19.26M 1.31B 19.47M 130M 51.15M 654M 51.59M 50.45M 2.16B
Net Debt 189M 28.01M 24.26M 22.61M 20.8M 39.26M 2.66B 39.7M 266M 104M 1.33B 105M 103M 4.41B -169M -25M -21.66M -20.19M -18.57M -35.05M -2.38B -35.44M -237M -93.11M -1.19B -93.91M -91.84M -3.94B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
05/08/26 CN¥8.030 +0.25% 13,798,929
04/08/26 CN¥8.010 +2.04% 13,878,553
03/08/26 CN¥7.850 +0.51% 10,037,400
31/07/26 CN¥7.810 +2.63% 14,775,420
30/07/26 CN¥7.610 -2.69% 17,979,359

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock